Un T4 décevant sur le B2B à mettre en perspective - ACHAT - OBJECTIF : 8,4€ (vs 9,5€)
Le T4 (-14% sur la CA) est venu interrompre la très forte dynamique de croissance sur les 9 premiers mois (+39%). Si ceci peut interroger, nous mettons cela sur le compte d’un accident de parcours, la réorganisation managériale au S2 2015 et la structuration de l’entreprise ayant grippé la dynamique. Les différents partenariats signés (Apicil, Le Noble Age) plaident en ce sens et confirment la capacité du groupe à s’imposer comme un acteur de référence sur un marché de la Silver Eco au potentiel significatif. Si nous abaissons par prudence nos attentes et notre objectif (8,4€ vs 9,5€ préc), nous referons un point au cours du S1 2016 afin de mieux appréhender les impacts de la stratégie de conquête de nouveaux abonnés B2C et du déploiement à l’international. ACHAT réitéré.Bluelinea S A. Bluelinea SA is a France-based company engaged in the medical sector. Bluelinea SA specializes in designing and developing electronic surveillance and medical teleassistance systems. It offers caregiver identification and authentication badges, individual protection bracelets for newborns, and home care and treatment devices for fragile or chronically ill elderly persons. The Company cooperates with Europe-based partners, including Everon Oy/Ab and Hager group, among others.
Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.
Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.